FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000417148> ?p ?o ?g. }

• W2000417148 endingPage "376" @default.
• W2000417148 startingPage "368" @default.
• W2000417148 abstract "The rates of glycerol and free fatty acid (FFA) kinetics in normal volunteers (VOL), non-weight-losing (NWL) gastrointestinal cancer patients, weight-losing (WL) gastrointestinal cancer patients, and in severely septic patients, using constant infusions of d-glycerol and 1-13C palmitic acid; were determined. Rates of FFA oxidation have also been quantitated. Measurements were made in the basal state, during glucose infusion (4 mg/kg/min), and during total parenteral nutrition (TPN). Rates of glycerol and FFA appearance (Ra) in volunteers and NWL cancer patients were similar, and in both groups there was a significant suppression after glucose infusion. The basal Ra values for glycerol and FFA were 2.4 +/- 0.2 and 6.5 +/- 0.8 mumol/kg/min, respectively, in the volunteers, and in the NWL cancer patients the corresponding values were 2.7 +/- 0.4 and 7.1 +/- 1.1 mumol/kg/min (not significantly different). Compared with the volunteers, the rates of glycerol and FFA turnover were significantly elevated in both septic patients and WL cancer patients. The values for glycerol and FFA Ra were 6.3 +/- 1.1 and 13.1 +/- 3.0 mumol/kg/min, respectively, in the septic patients. The corresponding values were 4.1 +/- 0.4 and 11.7 +/- 1.6 mumol/kg/min in the WL cancer patients. In contrast to the response seen in the volunteers and NWL cancer patients, glucose infusion did not suppress lipolysis in either the septic or WL cancer patients. In all groups studied, glucose infusion resulted in an increase in FFA recycling. Despite the fact that the WL cancer patients had an increased FFA availability, they were significantly less able to oxidize either endogenous FFA or infused lipid when compared with NWL cancer patients (the basal % of FFA uptake oxidized in WL cancer patients was 10 +/- 2% vs. 18 +/- 3% in NWL cancer patients). In contrast, the septic patients had an enhanced capacity to oxidize either endogenous FFA or infused lipid (the basal % of FFA uptake oxidized was 40 +/- 8%, and during TPN this increased in 65 +/- 10%). From these studies the following was concluded: in terms of lipid kinetics, NWL cancer patients are not significantly different from volunteers; WL cancer patients and septic patients have elevated rates of lipolysis, and in contrast to what was seen in NWL cancer patients and in volunteers, glucose infusion in WL cancer patients and in septic patients does not result in a significant inhibition of lipolysis; and WL cancer patients have an impaired capacity to oxidize either endogenous FFA or infused lipid.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2000417148 created "2016-06-24" @default.
• W2000417148 creator A5030635807 @default.
• W2000417148 creator A5060298854 @default.
• W2000417148 date "1987-04-01" @default.
• W2000417148 modified "2023-10-12" @default.
• W2000417148 title "Fatty Acid and Glycerol Kinetics in Septic Patients and in Patients with Gastrointestinal Cancer" @default.
• W2000417148 cites W132879182 @default.
• W2000417148 cites W1655991524 @default.
• W2000417148 cites W1883642995 @default.
• W2000417148 cites W1972087900 @default.
• W2000417148 cites W1972892862 @default.
• W2000417148 cites W1981936195 @default.
• W2000417148 cites W1990864039 @default.
• W2000417148 cites W2002139436 @default.
• W2000417148 cites W2017753537 @default.
• W2000417148 cites W2025639764 @default.
• W2000417148 cites W2032584864 @default.
• W2000417148 cites W2037312984 @default.
• W2000417148 cites W2044518726 @default.
• W2000417148 cites W2064920452 @default.
• W2000417148 cites W2073441087 @default.
• W2000417148 cites W2124232607 @default.
• W2000417148 cites W2139164844 @default.
• W2000417148 cites W2236270392 @default.
• W2000417148 cites W2404149746 @default.
• W2000417148 cites W2413468322 @default.
• W2000417148 cites W6779286 @default.
• W2000417148 cites W99176828 @default.
• W2000417148 doi "https://doi.org/10.1097/00000658-198704000-00005" @default.
• W2000417148 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1492741" @default.
• W2000417148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3105476" @default.
• W2000417148 hasPublicationYear "1987" @default.
• W2000417148 type Work @default.
• W2000417148 sameAs 2000417148 @default.
• W2000417148 citedByCount "179" @default.
• W2000417148 countsByYear W20004171482012 @default.
• W2000417148 countsByYear W20004171482013 @default.
• W2000417148 countsByYear W20004171482014 @default.
• W2000417148 countsByYear W20004171482015 @default.
• W2000417148 countsByYear W20004171482016 @default.
• W2000417148 countsByYear W20004171482017 @default.
• W2000417148 countsByYear W20004171482018 @default.
• W2000417148 countsByYear W20004171482019 @default.
• W2000417148 countsByYear W20004171482020 @default.
• W2000417148 countsByYear W20004171482021 @default.
• W2000417148 countsByYear W20004171482022 @default.
• W2000417148 crossrefType "journal-article" @default.
• W2000417148 hasAuthorship W2000417148A5030635807 @default.
• W2000417148 hasAuthorship W2000417148A5060298854 @default.
• W2000417148 hasBestOaLocation W20004171482 @default.
• W2000417148 hasConcept C121608353 @default.
• W2000417148 hasConcept C126322002 @default.
• W2000417148 hasConcept C134018914 @default.
• W2000417148 hasConcept C140985366 @default.
• W2000417148 hasConcept C141071460 @default.
• W2000417148 hasConcept C171089720 @default.
• W2000417148 hasConcept C185592680 @default.
• W2000417148 hasConcept C2778024521 @default.
• W2000417148 hasConcept C2779306644 @default.
• W2000417148 hasConcept C2779936771 @default.
• W2000417148 hasConcept C2780881558 @default.
• W2000417148 hasConcept C543025807 @default.
• W2000417148 hasConcept C55493867 @default.
• W2000417148 hasConcept C71924100 @default.
• W2000417148 hasConcept C90924648 @default.
• W2000417148 hasConceptScore W2000417148C121608353 @default.
• W2000417148 hasConceptScore W2000417148C126322002 @default.
• W2000417148 hasConceptScore W2000417148C134018914 @default.
• W2000417148 hasConceptScore W2000417148C140985366 @default.
• W2000417148 hasConceptScore W2000417148C141071460 @default.
• W2000417148 hasConceptScore W2000417148C171089720 @default.
• W2000417148 hasConceptScore W2000417148C185592680 @default.
• W2000417148 hasConceptScore W2000417148C2778024521 @default.
• W2000417148 hasConceptScore W2000417148C2779306644 @default.
• W2000417148 hasConceptScore W2000417148C2779936771 @default.
• W2000417148 hasConceptScore W2000417148C2780881558 @default.
• W2000417148 hasConceptScore W2000417148C543025807 @default.
• W2000417148 hasConceptScore W2000417148C55493867 @default.
• W2000417148 hasConceptScore W2000417148C71924100 @default.
• W2000417148 hasConceptScore W2000417148C90924648 @default.
• W2000417148 hasIssue "4" @default.
• W2000417148 hasLocation W20004171481 @default.
• W2000417148 hasLocation W20004171482 @default.
• W2000417148 hasLocation W20004171483 @default.
• W2000417148 hasOpenAccess W2000417148 @default.
• W2000417148 hasPrimaryLocation W20004171481 @default.
• W2000417148 hasRelatedWork W1979754845 @default.
• W2000417148 hasRelatedWork W2006513370 @default.
• W2000417148 hasRelatedWork W2009298935 @default.
• W2000417148 hasRelatedWork W2052941703 @default.
• W2000417148 hasRelatedWork W2070165532 @default.
• W2000417148 hasRelatedWork W2121710515 @default.
• W2000417148 hasRelatedWork W2142711007 @default.
• W2000417148 hasRelatedWork W2167005567 @default.
• W2000417148 hasRelatedWork W2175933285 @default.
• W2000417148 hasRelatedWork W2468120394 @default.
• W2000417148 hasVolume "205" @default.

• next